Industry: Drug Manufacturers - General
Organon & Co develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage.
Institution %: 80.792
YTD Institution change: 6252153
InsidersInsiders %: 0.157
Insiders Purchases YTD: 2720
Insiders Sales YTD:
Insiders Net YTD: 2720
Analyst RatingsTarget Price: 29.29
Overall Rating: 3.4444
Strong Buys (5): 1
Buys (4): 3
Holds (3): 4
Sells (2): 1
Strong Sells (1): 0
52 Week Hi: 22.5397
52 Week Low: 10.5257
Beta: 0.811
50 Day MA: 20.9122
200 Day MA: 17.2403
Earnings / Revenue TrendsQtr Earnings Growth YOY: 0.13
Qtr Revenue Growth YOY: 0.055
Forward PE:
Trailing PE: